Clinical trials
Observational Anemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 5 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| China-Japan Friendship Hospital | 3 |
| Peking University | 3 |
| Peking Union Medical College Hospital | 2 |
| Capital Medical University | 1 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 1 |
| Fudan University | 1 |
| Peking University First Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shenzhen Bao'an Maternal and Child Health Hospital | 1 |
| Zhejiang University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 16 |
| Hypertension, Pregnancy-Induced | 3 |
| Obesity | 3 |
| Diabetes, Gestational | 2 |
| Premature Birth | 2 |
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 |
| Enterocolitis, Necrotizing | 1 |
| Heart Failure | 1 |
| Hyperglycemia | 1 |
| Hyperlipidemias | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.